These effects, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the idea of concentrating on ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Conditions. Title your selection: Identify https://xiaopingo835nmn0.answerblogs.com/profile